Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

BACKGROUND: The CombiVacS study was designed to assess immunogenicity and reactogenicity of the heterologous ChAdOx1-S/BNT162b2 combination, and 14-day results showed a strong immune response. The present secondary analysis addresses the evolution of humoral and cellular response up to day 180. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Pérez, Javier, González-Pérez, María, Castillo de la Osa, María, Borobia, Alberto M., Castaño, Luis, Bertrán, María Jesús, Campins, Magdalena, Portolés, Antonio, Lora, David, Bermejo, Mercedes, Conde, Patricia, Hernández-Gutierrez, Lourdes, Carcas, Antonio, Arana-Arri, Eunate, Tortajada, Marta, Fuentes, Inmaculada, Ascaso, Ana, García-Morales, María Teresa, Erick de la Torre-Tarazona, Humberto, Arribas, José-Ramón, Imaz-Ayo, Natale, Mellado-Pau, Eugènia, Agustí, Antonia, Pérez-Ingidua, Carla, Gómez de la Cámara, Agustín, Ochando, Jordi, Belda-Iniesta, Cristobal, Frías, Jesús, Alcamí, José, Pérez-Olmeda, Mayte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249304/
https://www.ncbi.nlm.nih.gov/pubmed/35795713
http://dx.doi.org/10.1016/j.eclinm.2022.101529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249304/
https://www.ncbi.nlm.nih.gov/pubmed/35795713
http://dx.doi.org/10.1016/j.eclinm.2022.101529

Ejemplares similares